New Lawsuit alleges Yaz/Yasmin Caused Blood Clot

Share Article

According to court documents, on May 7th, 2012, New York residents Angela Wright and her husband filed a lawsuit in New York Northern District Court (case no. 5:2012cv00762) alleging that Wright developed a blood clot from Yaz. Yasmin, which was approved by the FDA in 2001, and Yaz, which was approved in 2006, are oral contraceptives that combine estrogen and a fourth generation progestin, drospirenone, to prevent pregnancy. They are also used to treat premenstrual dysphoric disorder (PMDD) and certain types of moderate acne in women. Yasmin and, its sister drug, Yaz are manufactured by Bayer Healthcare Pharmaceuticals. Now, AttorneyOne.com, a recognized authority on law, can provide helpful, proven advice and simple solutions including how to get in contact with legal counsel so anyone can easily and inexpensively deal with cases of alleged Yasmin severe adverse events. [http://www.attorneyone.com/yasmin/ .

Yasmin and Yaz: severe adverse events threat

Yasmin and Yaz: severe adverse events threat

drospirenone-containing birth control pills may be associated with a higher risk for blood clots

The media spotlight is often a double-edged sword. No one knows this better than Angela Wright and other women who filed a Yasmin Lawsuit. And yet, the real story here is being overlooked according to Sean Burke of AttorneyOne.

According to court documents, on May 7th, 2012, New York residents, Angela Wright, and her husband filed a lawsuit in New York Northern District Court (case no. 5:2012cv00762) alleging that Wright developed a blood clot from Yaz and Yasmin. Yasmin, which was approved by the FDA in 2001, and Yaz, which was approved in 2006, are oral contraceptives that combine estrogen and a fourth generation progestin, drospirenone, to prevent pregnancy. They are also used to treat premenstrual dysphoric disorder (PMDD) and certain types of moderate acne in women. Yasmin and, its sister drug, Yaz are manufactured by Bayer Healthcare Pharmaceuticals.

In the lawsuit plaintiff claims she took Yasmin and Yaz from January 2010 to June 2011. After the use of Yasmin and Yaz, Wright claims she suffered from severe adverse events including pulmonary embolism and deep vein thrombosis. As published on Bloomberg in April 2012, there were about 11,900 lawsuits pending in the United States served upon Bayer on behalf of persons alleged to have suffered personal injuries, some of them fatal, from the use of Yasmin and Yaz, as of April 18th, 2012.

AttorneyOne.com, a recognized authority on law, can provide helpful advice and simple solutions including how to get in contact with legal counsel so that, in case of alleged severe adverse events from Yasmin/Yaz, someone can easily and inexpensively deal with it. As Mr. Burke, director of Media Relations for AttorneyOne.com, added, “What all this information really illustrates is that alleged threat from Yasmin/Yaz remains. For that reason, our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”

On April 8th, 2012 the FDA issued a Drug Safety Communication informing the public it has completed its review of recent epidemiologic studies concluding that drospirenone-containing birth control pills may be associated with a higher risk for blood clots than other progestin-containing pills.

AttorneyOne.com has further information on Yasmin lawsuits including how to get in contact with legal counsel.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2012/7/prweb9672790.htm.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sean Burke
Visit website